USER LOGIN
Please login below to enter the professional site.
Username:

Password:

Forgot your password?
Sign-Up for Professional Membership
Retail Products
Retail Products Brochure
Product List, Pricing, and Online Sources
Why Adaptogens?
Practitioner Locator
Store Locator
Books
Natura in the Media
Click here to view and download the articles
Professional Library Preview
NEW! S-Clear Product Sheet
NEW! Botanabol Applied Research
NEW! Skin Protect Product Sheet
NEW! Skin Protect Applied Research
Technical Support
Login Troubleshooting
Attention MAC Users
Shipping Policies
Shopping Cart
Show Cart
Your Cart is currently empty.
Events PDF Print E-mail

Donnie Yance 2010 Lecture Schedule

To see a listing of past events, click here

January 29-31: Institute of Women’s Health "Women’s Cancer Seminars"

Portland, OR

www.instituteofwomenshealth.com

Collaborative Oncology: An Introduction to the Eclectic Triphasic Medical System (ETMS), a Clinical Holistic Approach to Cancer Care Utilizing Botanical and Nutritional Medicine as Targeted Therapies (1 hr)
This approach presents a multi-lens investigation, which examines the patient’s constitutional energetics, endogenous and exogenous factors, and specific biomarkers from blood, pathology and tissue testing. This information is used to strategically design protocols to alter the individual’s biological terrain, including gene behavior and expression, so that it is conducive to health and vitality while actively suppressing disease.

Cancer and Inflammation – The Role of Botanicals in Targeting Pro-inflammatory Pathways Relating to Cancer Activation and Promotion (1 hr)
This discussion centers on botanicals that modulate pro-inflammatory markers such as NF-kB, COX-2, LOX-5, 8, 1 and 15, AP-1, IL-6, IGF 1 and 2, CRP, TNF- α and other inducers of inflammation linked to pathways of cancer development.

Branch 3 of the ETMS - Biomarkers Related to Cancer Host and Tumor, Protocol Building, Case Studies (1 hr)
This presentation reviews categories of markers relating to cancer terrain, general and specific tumor markers and growth factors involved in angiogenesis.  Tumor sensitivity and resistance testing will also be discussed. Case study examples are presented to articulate specific botanical and nutritional protocols and strategies based on this information.  

February 19-21: "Healing the Brain" Conference

Hyatt Regency, Bellevue, WA

www.neuraltherapy.com

Neurological Health: Botanical and Nutritional Intervention for the Prevention and Treatment of Alzheimer’s Disease and other Dementias (2 hr)
This lecture presents the hallmark age-related neuro-pathological features that contribute to neurodegenerative disease resulting from chronic stress and inflammation to oxidative stress and insulin resistance. The connection between endocrine disruption, hormone deficiency and cognitive decline will be explained along with important diagnostic markers such as Apo E4, homocysteine, and CRP for assessing the risk of AD and other dementias. Effective botanical, nutritional, dietary and lifestyle solutions will be presented including anabolic, neurotrophic and neuroprotective compounds.

April 8-14: Annual Southwest Conference on Botanical Medicine

Southwest Naturopathic College, Tempe, AZ

www.botanicalmedicine.org

Cardiovascular Blood Markers and Botanical & Nutritional Therapies (3 hr)
Multiple factors contribute to atherosclerosis and CVD, often acting in a synergistic way to promote CVD; these include pro-inflammatory pathways, oxidation, methylation, hypercoagulation, nutrition etc. This presentation will identify key biochemical markers and specific tests for risk assessment such as NMR lipid profiling, fibrinogen, ferratin, CRP and hormone panels. Botanical and nutritional therapies for reducing these risks and restoring health will be discussed.

Targeted Botanical and Drug Therapies in Cancer – Branch 3 of the ETMS (1.5 hr)
The third branch of the Eclectic Triphasic Medical System involves an in-depth investigation of host and related tumor genomics. Often specific growth factors such as HER 1, HER 2, PDGF and VEGF are over expressed in cancer. The many pathways and downstream effectors of these major growth factors will be explained. The presentation will also identify the best choices of drug options to consider while demonstrating the important role of botanicals for achieving long-term effective results.

April 26-May 1: Mederi Foundation Clinical Training Program Level One – "Fundamentals of the Eclectic Triphasic Medical System" (ETMS)

Ashland, OR

www.mederifoundation.org

May 20-23: Institute for Functional Medicine’s (IFM) 17th International Symposium – "Assessment and Treatment of Cancer from a Functional Medicine Perspective"

La Costa Resort, Carlsbad, CA

www.functionalmedicine.org

"Botanical Medicine in Cancer: Case Series Results"
Through case study presentations, learn how the ETMS (Eclectic Triphasic Medical System) combines botanical medicine, nutritional agents and diet, together with personalized, target-specific pharmaceuticals, such as chemotherapy, Tyrosine Kinase inhibitors, and Monoclonal Antibodies, as the key principle therapies for the management of cancer to significantly improve patient quality of life and lifespan.

  • Review the scientific support of botanical and nutritional medicine in cancer and apply this knowledge in individualizing cancer care to the patient
  • Obtain skills in investigating and evaluating host and tumor pathology in order to appropriately apply adjunctive botanical and nutritional therapies
  • Through case study presentations, learn how to build a framework protocol including appropriate selection of botanical medicines and drug therapies based on this personalized approach

July 10-11: "BurlingtonFest" – Lectures for Healthcare Professionals

Burlington, VT

www.burlingtonfest.com

Collaborative Oncology: An Introduction to the Eclectic Triphasic Medical System (ETMS), a Clinical Holistic Approach to Cancer Care Utilizing Botanical and Nutritional Medicine as Targeted Therapies (3 hr)
This approach presents a multi-lens investigation, which examines the patient’s constitutional energetics, endogenous and exogenous factors, and specific biomarkers from blood, pathology and tissue testing. This information is used to strategically design protocols to alter the individual’s biological terrain, including gene behavior and expression, so that it is conducive to health and vitality while actively suppressing disease.

Copyright © 2005. Natura Health Products. All rights reserved.